11城药品集中采购试点全面落地,25种药品平均降价超一半

2019-04-01 车丽 央广网

据中国之声《新闻和报纸摘要》报道,今年初,国办印发《国家组织药品集中采购和使用试点方案》,选择北京、天津、上海、重庆、沈阳、大连、厦门、广州、深圳、成都和西安11个城市开展试点工作。截至目前,11个城市均已明确具体执行时间与细则,药品带量采购相继落地,25种药品平均降价52%。这次降价药品主要针对高血压、抑郁症、乙肝、肺癌等需要长期用药的慢性疾病,价格平均降幅在52%,最高降幅达96%。西安交通大

据中国之声《新闻和报纸摘要》报道,今年初,国办印发《国家组织药品集中采购和使用试点方案》,选择北京、天津、上海、重庆、沈阳、大连、厦门、广州、深圳、成都和西安11个城市开展试点工作。截至目前,11个城市均已明确具体执行时间与细则,药品带量采购相继落地,25种药品平均降价52%。

这次降价药品主要针对高血压、抑郁症、乙肝、肺癌等需要长期用药的慢性疾病,价格平均降幅在52%,最高降幅达96%。西安交通大学第二附属医院药学部主任张抗怀提到,患者药费负担明显减轻。

张抗怀:常用的降血脂药物阿托伐他汀,它的零售价39块多,这次执行之后它的价格降到了6块6,还有一些治疗乙肝的药物,比如恩替卡韦分散片,原来一盒的价格要200多,现在价格降到了17块多。

从3月25日起,西安带量采购试点正式全面执行国家组织药品集中采购结果,并同步执行医保支付标准。上海、深圳、天津、重庆、辽宁等地试点已于20日前开启。国家药品监督管理局药品监督管理司司长袁林表示,为确保此次中标药品“降价不降质”,会对中标的企业和中标的品种采取两个“全覆盖”。

袁林:对中标药品的原料也就是活性物质,还有主要的辅料加强监管;加强不良反应的监测。涉及到的处方工艺不是一成不变的,创新和变更也要进行相应的审批。我们要求企业必须严格依法依规按要求生产,坚决防止出现低价中标后生产低质甚至劣质药品危害公共健康,一旦出现这些问题,我们一定坚决打击毫不留情。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1694316, encodeId=1e02169431649, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Sun Dec 01 05:12:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641712, encodeId=59f71641e121d, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Sat Jan 04 04:12:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425103, encodeId=33921425103a7, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460121, encodeId=367f14601217c, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532850, encodeId=50d21532850c0, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1694316, encodeId=1e02169431649, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Sun Dec 01 05:12:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641712, encodeId=59f71641e121d, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Sat Jan 04 04:12:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425103, encodeId=33921425103a7, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460121, encodeId=367f14601217c, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532850, encodeId=50d21532850c0, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1694316, encodeId=1e02169431649, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Sun Dec 01 05:12:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641712, encodeId=59f71641e121d, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Sat Jan 04 04:12:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425103, encodeId=33921425103a7, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460121, encodeId=367f14601217c, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532850, encodeId=50d21532850c0, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
    2019-04-03 30397605
  4. [GetPortalCommentsPageByObjectIdResponse(id=1694316, encodeId=1e02169431649, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Sun Dec 01 05:12:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641712, encodeId=59f71641e121d, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Sat Jan 04 04:12:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425103, encodeId=33921425103a7, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460121, encodeId=367f14601217c, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532850, encodeId=50d21532850c0, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1694316, encodeId=1e02169431649, content=<a href='/topic/show?id=12a48e51263' target=_blank style='color:#2F92EE;'>#药品集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87512, encryptionId=12a48e51263, topicName=药品集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77629597748, createdName=cathymary, createdTime=Sun Dec 01 05:12:00 CST 2019, time=2019-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1641712, encodeId=59f71641e121d, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Sat Jan 04 04:12:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1425103, encodeId=33921425103a7, content=<a href='/topic/show?id=c1219810ebf' target=_blank style='color:#2F92EE;'>#降价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98107, encryptionId=c1219810ebf, topicName=降价)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6933946754, createdName=30397605, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460121, encodeId=367f14601217c, content=<a href='/topic/show?id=cb9d98e23ee' target=_blank style='color:#2F92EE;'>#集中采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98723, encryptionId=cb9d98e23ee, topicName=集中采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1406243727, createdName=liuxiaona, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532850, encodeId=50d21532850c0, content=<a href='/topic/show?id=88f395665de' target=_blank style='color:#2F92EE;'>#采购#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95665, encryptionId=88f395665de, topicName=采购)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9bb312387914, createdName=wolongzxh, createdTime=Wed Apr 03 03:12:00 CST 2019, time=2019-04-03, status=1, ipAttribution=)]
    2019-04-03 wolongzxh

相关资讯

国家药监局公布36批次药品不合格

2019年3月22日,国家药品监督管理局发布《关于31批次药品不符合规定的通告(2018年第53号)》。通告称,经江西省药品检验检测研究院等4家药品检验机构检验,标示为南京白敬宇制药有限责任公司等16家企业生产的36批次药品不符合规定。

这些药,开始大降价

海外原研药企若想保有一定量的中国市场,进口药价势必会维持较低的水平,甚至进一步下调。

11个药停止供货

日前,深圳全药网发布《关于公示4+7城市药品集中采购非中选药品深圳地区调整结果的通知》。

2018年 阿尔茨海默病领域的10大重磅交易

全球大约有几千万名的阿尔茨海默病患者。阿尔茨海默病患者的两大重要病理特征为大脑中的淀粉样蛋白(Aβ)沉积和神经细胞中tau蛋白聚集导致的神经原纤维缠结。

114药品大降价

昨日(3月26日),四川省药械招标采购服务中心发布《关于对国家组织药品集中采购非中选药品价格调整的通知》。

药品和疫苗应“一码到底”

去年以来,长生疫苗事件、金湖疫苗过期事件、石家庄疫苗调包事件等接连曝光,引起全社会对药品和疫苗安全问题的强烈关注。